SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950135-03-002623
Filing Date
2003-04-28
Accepted
2003-04-28 08:48:23
Documents
3
Period of Report
2003-06-10
Effectiveness Date
2003-04-28

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. b46298dfdef14a.htm DEF 14A 277299
3 COURTESY PDF b46298dfdef14axpdfy.pdf DEF 14A 356956
4 GRAPHIC b46298dfb4629800.gif GRAPHIC 8550
  Complete submission text file 0000950135-03-002623.txt   644587
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-29089 | Film No.: 03665646
SIC: 2836 Biological Products, (No Diagnostic Substances)